She's taking to X, formerly known as Twitter, to taunt her critics over the commercial.
From 1979 to 2007, Weekly World News transformed supermarket checkout lines into gateways to the absurd, serving up headlines about WWII Navy planes discovered near Mars, Bigfoot’s runaway bride, and ...
Faith-based development is having a moment in Southern California, where churches and other religious institutions control underused land in some of the communities most desperate for more housing.
The NFL's popular "RedZone" broadcast returns for its 18th season on Sunday, and while the focus is seemingly on how many commercials the previously commercial-free program will air, host Scott Hanson ...
Watching retro television commercials from the 1950s is a wild experience. Some have aged horribly, with racial stereotypes and outright sexism, not to mention the glamorization of smoking cigarettes.
Disney has already scored big for the 2027 Super Bowl, selling out ads that may have fetched up to $10 million. And ADWEEK is bringing them all to you here. Regarding Super Bowl LXI, airing live on ...
Ethos’ advertising budget increases 50% as it pours dollars on its celebrity influencer strategy. No one wants to think about needing, let alone buying, life insurance, said Dave Brown, Vice President ...
In a single news cycle, Pathos AI announced two simultaneous drug licensing agreements worth up to $2.3 billion in combined milestones — and disclosed that it is targeting a $300 million Series E ...
As well as $125 million in upfront cash for the license to JSKN016 outside Greater China, Alphamab is eligible to receive up to $2.09 billion in milestones. (Bet_Noire/iStock/Getty Images Plus) Pathos ...
Aug 4 (Reuters) - New York City-based Pathos AI will pay $125 million upfront to a subsidiary of Alphamab Oncology (9966.HK), opens new tab for rights to an experimental ‌drug for a type of breast ...
Pathos assumes responsibility for early clinical development of AZD4241, utilizing its AI-driven Foundry platform to drive patient stratification and trial design. NEW YORK--(BUSINESS WIRE)--Pathos AI ...